4 results
8-K
EX-99.1
TSVT
2seventy bio Inc
8 May 24
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
7:09am
are focused on reaching financial sustainability and creating value for shareholders,” said Chip Baird, CEO, 2seventy bio. “We have executed against
8-K
EX-99.1
TSVT
2seventy bio Inc
14 Jun 23
Unleash Time 2seventy bio company presentation June 2023
7:02am
Pipeline Drive toward $2-3B ABECMA U.S. peak sales potential* Path to profitability and sustainability Enabling partnerships Lever end-to-end cell therapy
8-K
EX-99.1
TSVT
2seventy bio Inc
10 Aug 22
Join the Patient Mission Company Presentation August 2022
12:13pm
Path to financial sustainability BOTTOM LINE 20232022 Next 3-5 Years Multiple partnerships in place to attack cancer *subject to FDA approval **based
10-12B/A
EX-10.22
TSVT
2seventy bio Inc
8 Oct 21
Registration of securities (amended)
4:43pm
such energy or sustainability requirements as may be adopted by the City of Cambridge or any other Governmental Authority from time to time, which information
- Prev
- 1
- Next